Effects of logo therapy on AIDS
Not Applicable
- Conditions
- Human immunodeficiency virus [HIV] disease.Human immunodeficiency virus [HIV] disease
- Registration Number
- IRCT2015031221445N1
- Lead Sponsor
- Welfare Organization of Guilan
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 24
Inclusion Criteria
at least educational level; without treating for depression
exclusion criteria: unwillingness to participate
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ife expectancy. Timepoint: Before intervention, after intervention. Method of measurement: Schneider life expectancy questionnaire.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie logo therapy's impact on HIV disease progression in IRCT2015031221445N1 trial?
How does logo therapy in IRCT2015031221445N1 compare to antiretroviral therapy in improving life expectancy for HIV patients?
What biomarkers predict response to logo therapy in IRCT2015031221445N1 HIV-infected individuals?
What adverse events are reported in IRCT2015031221445N1 logo therapy trials for AIDS patients and how are they managed?
Are there combination therapies involving logo therapy and ART in IRCT2015031221445N1 HIV disease study?